Barral-Netto M, Diez R, Badaró R, Sampaio D, Barral A, Carvalho E M, Falcoff E
Serviço de Imunologia, Hospital Prof. Edgard Santos, Universidade Federal de Bahia, Salvador, Brasil.
Braz J Med Biol Res. 1989;22(12):1485-7.
Serum from a significant proportion of 29 cutaneous and 12 mucocutaneous leishmaniasis patients exhibited interferon activity in a cytopathic assay: positive tests were obtained for 24.1% and 41.7% of the patients, respectively. Similar positive frequencies were observed in other parasitic diseases (schistosomiasis, 12.5%; toxoplasmosis, 20%; Chagas' disease, 16%; leprosy, 12.5%; tuberculosis, 30%). In contrast, none of the 44 serum samples from American visceral leishmaniasis (AVL) patients had interferon activity during the active stage of the disease. However, 13% of the samples obtained from patients recovered from AVL were positive.
在一项细胞病变试验中,29例皮肤利什曼病患者和12例黏膜皮肤利什曼病患者中相当一部分人的血清表现出干扰素活性:分别有24.1%和41.7%的患者检测呈阳性。在其他寄生虫病(血吸虫病,12.5%;弓形虫病,20%;恰加斯病,16%;麻风病,12.5%;结核病,30%)中也观察到了类似的阳性频率。相比之下,44例美洲内脏利什曼病(AVL)患者在疾病活动期的血清样本均无干扰素活性。然而,从康复的AVL患者中获得的样本有13%呈阳性。